Calvagone (France)

Recent papers from Calvagone (France)

1. Optimizing Perioperative Management of Haemophilia B With rFIX‐FP: Pharmacokinetic Validation of the Hemoptidose ToolHaemophilia · 2026
2. Comparison of dopamine D2 receptor occupancy profiles between risperidone ISM versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulationsExpert Review of Clinical Pharmacology · 2025
3. Comparison of dopamine D2 receptor occupancy profiles between risperidone ism versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulationsExpert Review of Clinical Pharmacology · 2025
4. From Radiocopper to Cold Copper: Mechanistic Modeling and Simulation to Define Clinical Response Criteria and Biomarkers for VTX ‐801 in Wilson DiseaseCPT Pharmacometrics & Systems Pharmacology · 2025
5. Exposure‐Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISMThe Journal of Clinical Pharmacology · 2024
6. Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®British Journal of Clinical Pharmacology · 2024
7. Development of a population pharmacokinetic model for the novel long-acting injectable antipsychotic Risperidone ISM®2024
8. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated AnalysisRheumatology and Therapy · 2024
9. Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in childrenCPT Pharmacometrics & Systems Pharmacology · 2024
10. Efficacy and safety of emapalumab in macrophage activation syndromeAnnals of the Rheumatic Diseases · 2023
11. Efficacy and safety of emapalumab in macrophage activation syndrome2022
12. Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approachBritish Journal of Clinical Pharmacology · 2021
13. Acute dose-response effect of coffee-derived chlorogenic acids on the human vasculature in healthy volunteers: a randomized controlled trialAmerican Journal of Clinical Nutrition · 2020
14. Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT ProlongationCPT Pharmacometrics & Systems Pharmacology · 2019
15. Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention diseaseJournal of Lipid Research · 2018